Amid Pyrophosphate Shortage, ASNC Issues Statement on How to Use HMDP as an Alternative Radiopharmaceutical in Cardiac Amyloidosis Imaging

FAIRFAX, VA (PRWEB) June 23, 2022 -- Shortages of pyrophosphate (PYP), the radiopharmaceutical most commonly used in the U.S. for noninvasive diagnosis of

Related Keywords

United States ,American ,Edwardj Miller ,Hydroxymethylene Diphosphonate ,Journal Of Nuclear Cardiology ,Yale School Of Medicine ,Nuclear Cardiology ,American Society Of Nuclear Cardiology ,American Society ,Supply Disruptions ,Tc Hydroxymethylene Diphosphonate ,Transthyretin Cardiac Amyloidosis ,Cardiovascular Medicine ,Yale School ,Cardiac Amyloidosis ,Imageguide Registry ,Press Release ,